Lilangi S. Ediriwickrema

Lilangi S. Ediriwickrema

Auto-generated profile, based on publicly available information

Lilangi S. Ediriwickrema

Gavin Herbert Eye Institute, Department of Ophthalmology, University of California Irvine, Irvine CA, United States

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2015 in Ocular Oncology and Pathology
Verified
Journal Article
Open access
PDF file
DZDagny Zhu
Dagny Zhu
Jesse BerryJesse Berry
Jesse Berry
LELilangi Ediriwickrema
Lilangi Ediriwickrema
KWKenneth Wong
Kenneth Wong
TLThomas C. Lee
Thomas C. Lee
RJRima Jubran
Rima Jubran
Background/Aims: Chemoreduction protocols for retinoblastoma vary widely across institutions. Herein, we compare a 3- versus 6-cycle chemotherapy approach for group B retinoblastoma. Methods: A nonrandomized, retrospective review of patients diagnosed with group B retinoblastoma from 1991-2011 at Children's Hospital Los Angeles was performed. A total of 72 eyes of 63 patients were analyzed. Mean follow-up time was 82 months (range 6-272 months). Main outcome measures were globe salvage and need for external beam radiation. Results: Forty-six patients (55 eyes) were treated upfront with 3 cycles of carboplatin, etoposide, and vincristine; 17 patients (17 eyes) received 6 cycles. Thirty-seven eyes (67%) in the 3-cycle group were cured with initial chemoreduction alone. An additional 10 eyes with persistent or recurrent tumors were rescued with 3 more cycles for a total salvage rate of 85% (47/55 eyes). In the 6-cycle group, 16 of 17 eyes (94%) avoided radiation and enucleation. Conclusion: The initial recurrence rate was higher for the 3-cycle group (p = 0.03). However, eyes failing short-course chemoreduction were rescued with 3 additional cycles and achieved a similar overall event-free survival rate (p = 0.16). In our cohort, this short-course approach spared 63% (29/46) of patients with group B retinoblastoma the extra 3 cycles of systemic chemotherapy.

18 April 2023 in medRxiv
Verified
Preprint
Open access
PDF file
JTJosiah To
Josiah To
AVAnderson N. Vu
Anderson N. Vu
LELilangi S. Ediriwickrema
Lilangi S. Ediriwickrema
ABAndrew W. Browne
Andrew W. Browne
Purpose: To compare a custom Photogrammetry for Anatomical CarE (PHACE) system with other cost-effective 3-dimensional (3D) facial scanning systems to objectively characterize morphology and volume of periorbital and adnexal anatomy. Methods: The imaging systems evaluated include the low-cost custom PHACE system and commercial software product for the iPhone called Scandy Pro (iScandy) application (Scandy, USA), and the mid-priced Einscan Pro 2X (Shining3D Technologies, China) device and Array of Reconstructed Cameras 7 (ARC7) facial scanner (Bellus3D, USA). Imaging was performed on a manikin facemask and humans with various Fitzpatrick scores. Scanner attributes were assessed using mesh density, reproducibility, surface deviation, and emulation of 3D printed phantom lesions affixed above the superciliary arch (brow line). Results: The Einscan served as a reference for lower cost imaging systems because it qualitatively and quantitatively renders facial morphology with the highest mesh density, reproducibility (0.13 ± 0.10 mm), and volume recapitulation (approximately 2% of 33.5 μL). Compared to the Einscan, the PHACE system (0.35 ± 0.03 mm, 0.33 ± 0.16 mm) demonstrated non-inferior mean accuracy and reproducibility root mean square (RMS) compared to the iScandy (0.42 ± 0.13 mm, 0.58 ± 0.09 mm), and significantly more expensive ARC7 (0.42 ± 0.03 mm, 0.26 ± 0.09 mm). Similarly, the PHACE system showed non-inferior volumetric modeling when rendering a 124 μL phantom lesion compared to the iScandy and more costly ARC7 (mean percent difference from the Einscan: 4.68 ± 3.73%, 9.09 ± 0.94%, and 21.99 ± 17.91% respectively). Conclusions: The affordable PHACE system accurately measures periorbital soft tissue as well as other established mid-cost facial scanning systems. Additionally, the portability, affordability, and adaptability of PHACE can facilitate widespread adoption of 3D facial anthropometric technology as an objective measurement tool in ophthalmology. Precis: We demonstrate a custom system for facial photogrammetry (Photogrammetry for Anatomical CarE -PHACE) to produce 3D renderings of facial volume and morphology which compares with more expensive alternative 3D scanning technologies.

21 April 2023 in medRxiv
Verified
Preprint
Open access
PDF file
JTJosiah To
Josiah To
JWJenny N. Wang
Jenny N. Wang
AVAnderson N. Vu
Anderson N. Vu
LELilangi S. Ediriwickrema
Lilangi S. Ediriwickrema
ABAndrew W. Browne
Andrew W. Browne
Introduction: Clinical tools are neither standardized nor ubiquitous to monitor volumetric or morphological changes in the periorbital region and ocular adnexa due to pathology such as oculofacial trauma, thyroid eye disease, and the natural aging process. We have developed a low-cost, three dimensionally printed PH otogrammetry for A utomated C ar E (PHACE) system to evaluate three-dimensional (3D) measurements of periocular and adnexal tissue. Methods: The PHACE system uses two Google Pixel 3 smartphones attached to automatic rotating platforms to image a subject’s face through a cutout board patterned with registration marks. Photographs of faces were taken from many perspectives by the cameras placed on the rotating platform. Faces were imaged with and without 3D printed hemispheric phantom lesions (black domes) affixed on the forehead above the brow. Images were rendered into 3D models in Metashape (Agisoft, St. Petersburg, Russia) and then processed and analyzed in CloudCompare (CC) and Autodesk’s Meshmixer. The 3D printed hemispheres affixed to the face were then quantified within Meshmixer and compared to their known volumes. Finally, we compared digital exophthalmometry measurements with results from a standard Hertel exophthalmometer in a subject with and without an orbital prosthesis. Results: Quantification of 3D printed phantom volumes using optimized stereophotogrammetry demonstrated a 2.5% error for a 244μL phantom, and 7.6% error for a 27.5μL phantom. Digital exophthalmometry measurements differed by 0.72mm from a standard exophthalmometer. Conclusion: We demonstrated an optimized workflow using our custom apparatus to analyze and quantify oculofacial volumetric and dimensions changes with a resolution of 244μL. This apparatus is a low-cost tool that can be used in clinical settings to objectively monitor volumetric and morphological changes in periorbital anatomy.

1 August 2024 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
LELilangi S. Ediriwickrema
Lilangi S. Ediriwickrema
SSShijun Sung
Shijun Sung
KMKaylyn C. Mattick
Kaylyn C. Mattick
MAMiranda B. An
Miranda B. An
CMClaire Malley
Claire Malley
ADAnthony J. Durkin
Anthony J. Durkin
Periocular inflammatory and infiltrative conditions are of particular importance given the proximity to the eye, thereby raising the risk for dry eyes, exposure keratopathy, eyelid malposition, blurry vision, eye pain, vision loss, double vision, and rarely, extension to the central nervous system. Diseases that affect the region include thyroid eye disease, rosacea, and eczema, as well as basal cell carcinoma, squamous cell carcinoma, melanoma, and vascular malformations. Clinical diagnosis and management of these diseases are oftentimes dependent on invasive, time-intensive, and costly procedures and testing, as well as immunotherapy, surgical resection, and periocular reconstruction. Non-invasive objective approaches to measuring local inflammation and infiltration are therefore needed to better quantify disease activity, progression, and treatment response.

1 August 2017 in Advances in Ophthalmology and Optometry
Verified
Journal Article
Closed access
LELilangi S. Ediriwickrema
Lilangi S. Ediriwickrema
DGDaniel R. Gold
Daniel R. Gold

23 October 2026 in American Journal of Ophthalmology Case Reports
Verified
Journal Article
Open access
MJMegan Jung
Megan Jung
KMKapil Mishra
Kapil Mishra
LELilangi S. Ediriwickrema
Lilangi S. Ediriwickrema